All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 3

In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference

Read the full article

You might also wanna read

One-Time Gene Therapy Restores Vision in 6-Year-Old with Rare Congenital Blindness

Saffie Sandford from Stevenage was diagnosed with Leber's Congenital Amaurosis, (LCA) a mutation in the RPE 65 gene.

goodnewsnetwork.org·26d ago

Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)

Conditions : Leber Congenital Amaurosis; Leber Congenital Amaurosis (LCA); LCA5 Interventions : Drug: OPGx-RDH12 Sponsors : Opus Genetics, I

clinicaltrials.gov·10d ago

Hematopoietic stem cell gene therapy delivers cell-penetrating frataxin to treat Friedreich's ataxia in preclinical models

Engineered hematopoietic stem cells delivering a secreted, tissue-penetrating frataxin restore mitochondrial function and ameliorate disease

cell.com·27d ago

Single CRISPR infusion reduces hereditary angioedema attacks by 87% in phase 3 trial

A single intravenous dose of Intellia Therapeutics’ in vivo CRISPR-Cas9 therapy lonvoguran ziclumeran (lonvo-z) reduced monthly hereditary a

crisprmedicinenews.com·26d ago

Life Biosciences Conducts First Gene Therapy Trial to Reverse Cellular Aging in Patient with Glaucoma

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The ris

popularmechanics.com·20d ago

Neurogene Completes Dosing in Registrational Trial of NGN-401 Gene Therapy for Rett Syndrome; Topline Data Expected 2H 2027

Trial success hinges on 8 of 24 participants meeting Neurogene’s composite endpoint. Dosing is complete; topline Rett gene therapy data expe

stocktitan.net·1mo ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.